Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-587.72	-111.10	-16.16
Graham Fair Price	-62.94	0.93	2.51
PEG	2326.91	0.22	< 0.005
Price/Book	-21.64	1.85	2.36
Price/Cash Flow	-72.52	-25.24	91.85
Prices/Earnings	-604.71	-19.67	-2.79
Price/Sales	275.26	19.40	5.17
Price/FCF	-72.52	-25.24	91.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-30.77	0.10	-0.14
Operating Margin	45.41	-0.28	-0.52
ROA	87.64	< 0.005	-0.05
ROE	-0.21	-0.02	88.88
ROIC	-0.08	< 0.005	87.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	0.10	-25.25
Dividends QOQ	-0.81	5.17	536.09
EBIT QOQ	-2.89	0.88	-69.46
EPS QOQ	-3.01	0.88	-70.96
FCF QOQ	2.63	-3.95	50.10
Revenue QOQ	0.73	-0.78	7.86
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3.71	17.00	358.37
Days Sales Outstanding (DSO)	486.12	2061.05	323.98
Inventory Turnover	24.27	5.29	-78.18
Debt/Capitalization	0.62	0.59	-3.75
Quick Ratio	1.41	1.41	-0.13
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.15	1.28	11.14
Cash	0.49	0.36	-27.34
Capex	< 0.005	< 0.005	-368.10
Free Cash Flow	0.03	-0.09	216.88
Revenue	0.52	0.12	-76.79
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.43	1.48	2.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.43	-43.26	-696.55
Naive Interpretation	Member

06 - Financial Health · Weak

Rating